Global Information
회사소개 | 문의

세계의 동물 백신 시장(2018-2022년)

Global Animal Vaccines Market 2018-2022

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2018년 10월 상품 코드 311854
페이지 정보 영문 115 Pages
가격
US $ 2,500 ₩ 2,848,500 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,418,200 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,557,600 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,697,000 PDF by E-mail (Global license) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 동물 백신 시장(2018-2022년) Global Animal Vaccines Market 2018-2022
발행일 : 2018년 10월 페이지 정보 : 영문 115 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계 동물 백신 시장은 2018-2023년간 4.84%의 연평균 복합 성장률(CAGR)로 확대될 전망입니다.

세계의 동물 백신(Animal Vaccines) 시장 현황과 향후 전망에 대해 조사했으며, 백신 종류·동물 종류·지역별 시장 성장 예측, 시장 영향요인과 과제, 경쟁 환경과 시장 점유율, 주요 기업 및 주목 기업 개요 등을 정리했습니다.

제1장 주요 요약

제2장 본 보고서의 조사 범위

제3장 조사 방법

제4장 시장 구도

  • 시장 생태계
  • 시장의 특징
  • 시장 부문 분석

제5장 시장 규모

  • 시장 정의
  • 시장 규모
  • 시장 규모와 예측

제6장 Five Forces 분석

제7장 인가된 동물 백신

  • 주요 백신

제8장 백신 종류별 시장 세분화

  • Segmentation by vaccine type
  • Comparison by vaccine type
  • Inactivated vaccines : 시장 규모와 예측
  • Live attenuated vaccines : 시장 규모와 예측
  • Recombinant vaccines : 시장 규모와 예측
  • Toxoid vaccines : 시장 규모와 예측
  • DNA vaccines : 시장 규모와 예측
  • 시장 기회

제9장 동물 종류별 시장 세분화

  • 용도별 세분화
  • 돼지용 백신
  • 가금류용 백신
  • 가축용 백신
  • 애완동물용 백신
  • 어개류용 백신 및 기타 백신

제10장 고객 현황

제11장 지역 현황

  • 지역 세분화
  • 지역 비교
  • 아메리카 : 시장 규모와 예측
  • 유럽, 중동 및 아프리카 : 시장 규모와 예측
  • 아시아태평양 : 시장 규모와 예측
  • 시장 기회

제12장 의사결정 프레임워크

제13장 시장 성장요인과 과제

  • 시장 성장요인
  • 시장이 해결해야 할 과제

제14장 시장 동향

제15장 벤더 구도

  • 개요
  • 파괴적 혁신

제16장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Bayer
  • Eli Lilly(Elanco Animal Health)
  • Merck
  • Boehringer Ingelheim

제17장 부록

  • 약어 리스트
LSH 18.11.09

About Animal Vaccines

Animal vaccines are biological preparations used to stimulate the immune system of animals to develop adaptive immunity to a pathogen. All animal vaccines undergo regulatory approval processes, the same as human vaccines, before they gain a product license for sale.

Technavio's analysts forecast the Global Animal Vaccines Market to grow at a CAGR of 4.84% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the animal vaccines market. To calculate the market size, the report considers the revenue generated from the retail sales of animal vaccines across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Animal Vaccines Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bayer
  • Eli Lilly (Elanco Animal Health)
  • Merck
  • Boehringer Ingelheim

Market driver

  • Increase in demand for livestock products
  • For a full, detailed list, view our report

Market challenge

  • Difficulties associated with animal vaccine storage and handling
  • For a full, detailed list, view our report

Market trend

  • Different vaccine delivery routes based on the target species
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: APPROVED ANIMAL VACCINES

  • Leading approved animal vaccines

PART 08: MARKET SEGMENTATION BY VACCINE TYPE

  • Segmentation by vaccine type
  • Comparison by vaccine type
  • Inactivated vaccines - Market size and forecast 2017-2022
  • Live attenuated vaccines - Market size and forecast 2017-2022
  • Recombinant vaccines - Market size and forecast 2017-2022
  • Toxoid vaccines - Market size and forecast 2017-2022
  • DNA vaccines - Market size and forecast 2017-2022
  • Market opportunity by vaccine type

PART 09: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Porcine vaccines
  • Poultry vaccines
  • Livestock vaccines
  • Companion animal vaccines
  • Aquaculture and other vaccines

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

  • Different vaccine delivery routes based on the target species
  • Increasing adoption of companion animals
  • Changing landscape of the infectious diseases in animals
  • Multiple purposes of veterinary vaccination

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer
  • Eli Lilly (Elanco Animal Health)
  • Merck
  • Boehringer Ingelheim

PART 17: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global vaccines market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global animal vaccines market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global animal vaccines market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Leading animal vaccines approved in major markets
  • Exhibit 19: Global animal vaccines market by vaccine type - Market share 2017-2022 (%)
  • Exhibit 20: Comparison by vaccine type
  • Exhibit 21: Inactivated vaccines - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 22: Inactivated vaccines - Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Live attenuated vaccines - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Live attenuated vaccines - Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Recombinant vaccines - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 26: Recombinant vaccines - Year-over-year growth 2018-2022 (%)
  • Exhibit 27: Toxoid vaccines - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 28: Toxoid vaccines - Year-over-year growth 2018-2022 (%)
  • Exhibit 29: DNA vaccines - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 30: DNA vaccines - Year-over-year growth 2018-2022 (%)
  • Exhibit 31: Market opportunity by vaccine type
  • Exhibit 32: Customer landscape
  • Exhibit 33: Global animal vaccines market by geography - Market share 2017-2022 (%)
  • Exhibit 34: Regional comparison
  • Exhibit 35: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 37: Top 3 countries in Americas
  • Exhibit 38: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 39: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 40: Top 3 countries in EMEA
  • Exhibit 41: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 42: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 43: Top 3 countries in APAC
  • Exhibit 44: Market opportunity
  • Exhibit 45: Vendor landscape
  • Exhibit 46: Landscape disruption
  • Exhibit 47: Vendors covered
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: Bayer: Overview
  • Exhibit 51: Bayer - Business segments
  • Exhibit 52: Bayer - Organizational developments
  • Exhibit 53: Bayer - Geographic focus
  • Exhibit 54: Bayer - Segment focus
  • Exhibit 55: Bayer - Key offerings
  • Exhibit 56: Eli Lilly (Elanco Animal Health): Overview
  • Exhibit 57: Eli Lilly (Elanco Animal Health) - Business segments
  • Exhibit 58: Eli Lilly (Elanco Animal Health)- Organizational developments
  • Exhibit 59: Eli Lilly (Elanco Animal Health) - Geographic focus
  • Exhibit 60: Eli Lilly (Elanco Animal Health) - Segment focus
  • Exhibit 61: Eli Lilly (Elanco Animal Health) - Key offerings
  • Exhibit 62: Merck: Overview
  • Exhibit 63: Merck - Business segments
  • Exhibit 64: Merck - Organizational developments
  • Exhibit 65: Merck - Geographic focus
  • Exhibit 66: Merck - Segment focus
  • Exhibit 67: Merck - Key offerings
  • Exhibit 68: Boehringer Ingelheim: Overview
  • Exhibit 69: Boehringer Ingelheim - Business segments
  • Exhibit 70: Boehringer Ingelheim - Organizational developments
  • Exhibit 71: Boehringer Ingelheim - Geographic focus
  • Exhibit 72: Boehringer Ingelheim - Segment focus
  • Exhibit 73: Boehringer Ingelheim - Key offerings
Back to Top
전화 문의
이용안내
 
BCC Research